Article

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients

2023-01-10

Abstract excerpt

<title>Abstract</title> <p>Cancer of unknown primary (CUP) is a type of cancer that cannot be traced back to its original site and accounts for 3-5% of all cancers. It does not have established targeted therapies, leading to poor outcomes. We developed OncoNPC, a machine learning classifier trained on targeted next-generation sequencing data from 34,567 tumors from three institutions. OncoNPC achieved a weighted...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a0f9cf4e-ac75-5446-be4d-620a9dc5e40a
DOI: 10.21203/rs.3.rs-2450090/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patientsDOI 10.21203/rs.3.rs-2450090/v1Read

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patientsSemantic proximity Read

Real-world data analysis of patients with cancer of unknown primarySemantic proximity Read

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.Semantic proximity Read

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.Semantic proximity Read

Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.Semantic proximity Read

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primarySemantic proximity Read

Cancer of unknown primary (CUP) through the lens of precision oncology – a single institution perspectiveSemantic proximity Read

A prospective national precision medicine trial comparing blood and tissue profiling in patients with Cancer of Unknown Primary (CUPCOMP)Semantic proximity Read

Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primarySemantic proximity Read

Cancer of unknown primary.Semantic proximity Read

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.Semantic proximity Read

Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features.Semantic proximity Read